A detailed history of Dai Ichi Life Insurance Company, LTD transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Dai Ichi Life Insurance Company, LTD holds 2,430 shares of CRL stock, worth $398,009. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,430
Previous 3,430 29.15%
Holding current value
$398,009
Previous $708,000 32.49%
% of portfolio
0.01%
Previous 0.02%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$187.96 - $245.29 $187,960 - $245,290
-1,000 Reduced 29.15%
2,430 $478,000
Q2 2024

Aug 08, 2024

SELL
$206.39 - $268.73 $1.24 Million - $1.61 Million
-6,000 Reduced 63.63%
3,430 $708,000
Q4 2023

Feb 09, 2024

SELL
$164.52 - $238.84 $2.94 Million - $4.26 Million
-17,850 Reduced 65.43%
9,430 $2.23 Million
Q3 2023

Nov 02, 2023

SELL
$194.44 - $217.61 $342,992 - $383,864
-1,764 Reduced 6.07%
27,280 $5.35 Million
Q2 2023

Aug 11, 2023

BUY
$183.71 - $210.25 $615,428 - $704,337
3,350 Added 13.04%
29,044 $6.11 Million
Q1 2023

May 15, 2023

SELL
$191.89 - $259.92 $2.69 Million - $3.64 Million
-14,000 Reduced 35.27%
25,694 $5.19 Million
Q2 2022

Aug 12, 2022

BUY
$204.13 - $302.4 $39,601 - $58,665
194 Added 0.49%
39,694 $8.49 Million
Q1 2022

May 13, 2022

BUY
$255.51 - $362.11 $511,020 - $724,220
2,000 Added 5.33%
39,500 $11.2 Million
Q4 2021

Feb 11, 2022

BUY
$351.38 - $448.68 $3.34 Million - $4.26 Million
9,500 Added 33.93%
37,500 $14.1 Million
Q2 2021

Aug 13, 2021

BUY
$294.17 - $371.65 $2.35 Million - $2.97 Million
8,000 Added 40.0%
28,000 $10.4 Million
Q1 2021

May 13, 2021

BUY
$249.67 - $299.48 $4.99 Million - $5.99 Million
20,000 New
20,000 $5.8 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.33B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Dai Ichi Life Insurance Company, LTD Portfolio

Follow Dai Ichi Life Insurance Company, LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dai Ichi Life Insurance Company, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dai Ichi Life Insurance Company, LTD with notifications on news.